A new research report appearing in the Journal of Leukocyte Biology suggests that the dose and number of viruses involved in initial infection is important and could pave the way for new prophylactic strategies to fight flu infections and provides a novel basis for vaccine design.
“Hopefully, the findings of our study will help to develop better vaccine preparations that will be more effective in inducing protective cellular immunity to fight against infectious pathogens such as bacteria, viruses and fungi,” said Martin V. Richter, Ph.D., the lead researcher involved in the work from the Department of Medicine at the UniversitÃ© de Sherbrooke and Centre de Recherche Clinique Ãtienne-Le Bel in QuÃ©bec, Canada.
“While considerable efforts have been invested in predicting new emerging flu strains for our yearly vaccines, it is impossible to prepare for every possible way the flu can mutate. This new research shows that it may be possible to enhance current vaccines to offer broader protection against different flu strains, known and unknown.”
Dr. Martin Richter will be presenting his findings at Terrapinn's 4th Annual Influenza Congress USA this November in Washington D.C.
To find out more about the event, click here:
For the original article click here: